Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 6/20 | 0.52 |
| ▸ | THRB | P10828 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 3/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | RORC | P51449 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29554999 | 1.00 | ALDH1A1 (0.55) | ALDH1A1HIF1AMAPTTHRBMAPK1 | |
| SCHEMBL16960109 | 0.87 | ALDH1A1 (0.56) | ALDH1A1HIF1AMAPTTHRBMAPK1 | |
| SCHEMBL1360146 | 0.86 | MAPT (0.56) | ALDH1A1HIF1AMAPTTHRBMAPK1 | |
| SCHEMBL31509357 | 0.86 | MAPT (0.56) | ALDH1A1HIF1AMAPTTHRBMAPK1 | |
| SCHEMBL2892696 | 0.84 | ALDH1A1 (0.53) | ALDH1A1HIF1AMAPTTHRBMAPK1 | |
| SCHEMBL31246234 | 0.84 | ALDH1A1 (0.53) | ALDH1A1HIF1AMAPTTHRBMAPK1 | |
| SCHEMBL4327681 | 0.84 | ALDH1A1 (0.53) | ALDH1A1HIF1AMAPTTHRBMAPK1 | |
| SCHEMBL195145 | 0.84 | ALDH1A1 (0.59) | ALDH1A1HIF1AMAPTSMN1; SMN2HTT | |
| SCHEMBL1654660 | 0.84 | ALDH1A1 (0.59) | ALDH1A1HIF1AMAPTSMN1; SMN2HTT | |
| SCHEMBL3656114 | 0.83 | MAPK1 (0.57) | ALDH1A1MAPTTHRBMAPK1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 370 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-7196644-A | — | — | None | — | — | JP | disclosed |
| US-20260125372-A1 | DYNAMIN-1-LIKE PROTEIN INHIBITORS AND USES THEREOF | ASTELLAS ENG SMALL MOLECULES US INCORPORATED (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260034140-A1 | MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE | REDX PHARMA LTD (GB) | 2026-02-05 | — | — | US | disclosed |
| US-20250353819-A1 | ARYL HYDANTOIN COMPOUNDS AND METHODS OF USE | BOARD OF REGENTS THE UNIV OF NEBRASKA (US) | 2025-11-20 | — | — | US | disclosed |
| US-12453734-B2 | Modulators of rho-associated protein kinase | REDX PHARMA LIMITED (GB) | 2025-10-28 | — | — | US | disclosed |
| US-20240216386-A1 | MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE | REDX PHARMA LIMITED (GB) | 2024-07-04 | — | — | US | disclosed |
| CN-114437062-B | Compound capable of being used as sodium channel regulator and application thereof | 成都海博为药业有限公司 | 2024-05-17 | — | — | CN | disclosed |
| US-11878020-B2 | Modulators of Rho-associated protein kinase | REDX PHARMA PLC (GB) | 2024-01-23 | — | — | US | disclosed |
| WO-2023235480-A1 | ARYL HYDANTOIN COMPOUNDS AND METHODS OF USE | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 2023-12-07 | — | — | WO | disclosed |
| US-20230303497-A1 | BENZYLAMINE OR BENZYL ALCOHOL DERIVATIVE AND USES THEREOF | CHENGDU HYPERWAY PHARMACEUTICALS CO., LTD (CN) | 2023-09-28 | — | — | US | disclosed |
| WO-1999035132-A1 | HETEROCYCLIC COMPOUNDS | GLAXO GROUP LIMITED (GB) | 1999-07-15 | — | — | WO | disclosed |
| WO-1999035146-A1 | BICYCLIC HETEROAROMATIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS | GLAXO GROUP LIMITED (GB) | 1999-07-15 | — | — | WO | disclosed |
| EP-0912559-A1 | FUSED HETEROCYCLIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS | GLAXO GROUP LIMITED (GB) | 1999-05-06 | — | — | EP | disclosed |
| EP-0912570-A1 | BICYCLIC HETEROAROMATIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS | GLAXO GROUP LIMITED (GB) | 1999-05-06 | — | — | EP | disclosed |
| EP-0842148-A1 | BENZENESULPHONAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTICAL USES THEREOF | SYNTHELABO (FR) | 1998-05-20 | — | — | EP | disclosed |
| WO-1998002434-A1 | FUSED HETEROCYCLIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS | GLAXO GROUP LIMITED (GB) | 1998-01-22 | — | — | WO | disclosed |
| WO-1998002438-A1 | BICYCLIC HETEROAROMATIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS | GLAXO GROUP LIMITED (GB) | 1998-01-22 | — | — | WO | disclosed |
| WO-1997006136-A1 | BENZENESULPHONAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTICAL USES THEREOF | SYNTHELABO (FR) | 1997-02-20 | — | — | WO | disclosed |
| JP-H07196644-A | BENZOPYRANE DERIVATIVE | CHUGAI PHARMACEUT CO LTD | 1995-08-01 | — | — | JP | disclosed |
| US-4801717-A | PLANT GROWTH REGULATORS | ROUSSEL UCLAF (FR) | 1989-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034140-A1 | MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE | ROCK1, ROCK2, RHOA | ALDH1A1 4825/4885HIF1A 4316/4885MAPT 614/4885 |
| US-12453734-B2 | Modulators of rho-associated protein kinase | ROCK2, ROCK1, RHOA | ALDH1A1 4441/4885HIF1A 3233/4885MAPT 909/4885 |
| US-20240216386-A1 | MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE | ROCK2, ROCK1, RHOA | ALDH1A1 4441/4885HIF1A 3233/4885MAPT 909/4885 |
| US-20250353819-A1 | ARYL HYDANTOIN COMPOUNDS AND METHODS OF USE | XDH, NAT1, HAX1 | ALDH1A1 174/4885HIF1A 895/4885MAPT 4764/4885 |
| US-20230303497-A1 | BENZYLAMINE OR BENZYL ALCOHOL DERIVATIVE AND USES THEREOF | SCN8A, SCN9A, SCN10A | ALDH1A1 1050/4885HIF1A 2630/4885MAPT 1923/4885 |
| US-20260125372-A1 | DYNAMIN-1-LIKE PROTEIN INHIBITORS AND USES THEREOF | DNM1L, DNM1, DNM2 | ALDH1A1 4578/4885HIF1A 1995/4885MAPT 1871/4885 |
| US-11878020-B2 | Modulators of Rho-associated protein kinase | ROCK2, ROCK1, RHOA | ALDH1A1 4441/4885HIF1A 3233/4885MAPT 909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.